Delivery Order SPE2DB24D1007-SPE2DB25FCBHH
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,566,503,281 units of the diabetes medication Dapagliflozin 5 mg tablets. The $1,447.39 contract has a completion date of November 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a $1,683.85 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,088,963 tablets of the diabetes medication dapagliflozin 10 mg, with a performance period ending on May 1, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,924,030 tablets of the diabetes medication dapagliflozin 10 mg. The $5,748.76 firm fixed-price delivery order has an ultimate completion date of April 16, 2025 and is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $1,111.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,908,355 units of the drug dapagliflozin 10 mg tablets in 30-count packages. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,232,835 units of the pharmaceutical drug dapagliflozin 10 mg tablet in 30-count packages. The award has a ceiling value of $1,202.59 and a period of performance through May 14, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,762.40, is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of March 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,907.28 firm fixed-price contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,961.68, is for the delivery of 4,568,120 units of the prescription medication dapagliflozin 10 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of May 5, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a $1,584.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication. The contract does not have a set-aside designation, indicating it was openly competed. The contract has an ultimate completion date of May 16, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,396.00 delivery order is for the supply of 4,564,766,189 units of the prescription medication Dapagliflozin 10 mg tablets. The contract has a firm-fixed price and is not set aside for any specific business category. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that...